Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 422Neoplasms 288Carcinoma, Non-Small-Cell Lung 276Colorectal Neoplasms 237Prostatic Neoplasms 176Lung Neoplasms 172Carcinoma, Hepatocellular 159Stomach Neoplasms 126Leukemia, Myeloid, Acute 121Pancreatic Neoplasms 118Multiple Myeloma 105Recurrence 100Uterine Cervical Neoplasms 98Neoplasm Metastasis 90Squamous Cell Carcinoma of Head and Neck 89Rectal Neoplasms 86Ovarian Neoplasms 84Triple Negative Breast Neoplasms 77Small Cell Lung Carcinoma 73Head and Neck Neoplasms 72Brain Neoplasms 69Esophageal Neoplasms 65Glioblastoma 64Endometrial Neoplasms 62Colonic Neoplasms 59Melanoma 57Hematologic Neoplasms 54Motor Activity 49Glioma 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 47

Interventions

Radiotherapy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × HER2-Negative Locally Advanced Breast Cancer × Clear all
NCT06908668 2025-04-03

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
170 enrolled
Breast

HER2-Negative Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡